Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-08-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512623002011 |
| _version_ | 1797749113463242752 |
|---|---|
| author | Marco B. Costanza, BS Kelly A. Reynolds, MD Julie E. Mervak, MD |
| author_facet | Marco B. Costanza, BS Kelly A. Reynolds, MD Julie E. Mervak, MD |
| author_sort | Marco B. Costanza, BS |
| collection | DOAJ |
| first_indexed | 2024-03-12T16:15:34Z |
| format | Article |
| id | doaj.art-7a6ac8b5696941909addf3291e8f1aed |
| institution | Directory Open Access Journal |
| issn | 2352-5126 |
| language | English |
| last_indexed | 2024-03-12T16:15:34Z |
| publishDate | 2023-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD Case Reports |
| spelling | doaj.art-7a6ac8b5696941909addf3291e8f1aed2023-08-09T04:33:09ZengElsevierJAAD Case Reports2352-51262023-08-01386163Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointmentMarco B. Costanza, BS0Kelly A. Reynolds, MD1Julie E. Mervak, MD2University of Michigan Medical School, Ann Arbor, MichiganDepartment of Dermatology, University of Michigan, Ann Arbor, MichiganDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan; Correspondence to: Julie E. Mervak, MD, Department of Dermatology, University of Michigan, 1500 E Medical Center Drive, SPC 5314/TC 1910, Ann Arbor, MI 48109.http://www.sciencedirect.com/science/article/pii/S2352512623002011adalimumabangiolupoid sarcoidosiscutaneous sarcoidosisJAK inhibitorTNF-α inhibitortofacitinib |
| spellingShingle | Marco B. Costanza, BS Kelly A. Reynolds, MD Julie E. Mervak, MD Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment JAAD Case Reports adalimumab angiolupoid sarcoidosis cutaneous sarcoidosis JAK inhibitor TNF-α inhibitor tofacitinib |
| title | Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment |
| title_full | Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment |
| title_fullStr | Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment |
| title_full_unstemmed | Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment |
| title_short | Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment |
| title_sort | management of treatment resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2 ointment |
| topic | adalimumab angiolupoid sarcoidosis cutaneous sarcoidosis JAK inhibitor TNF-α inhibitor tofacitinib |
| url | http://www.sciencedirect.com/science/article/pii/S2352512623002011 |
| work_keys_str_mv | AT marcobcostanzabs managementoftreatmentresistantangiolupoidsarcoidosiswithadalimumabandtofacitinib2ointment AT kellyareynoldsmd managementoftreatmentresistantangiolupoidsarcoidosiswithadalimumabandtofacitinib2ointment AT julieemervakmd managementoftreatmentresistantangiolupoidsarcoidosiswithadalimumabandtofacitinib2ointment |